期刊文献+

苯甲酸阿格列汀的合成及其初步质量研究 被引量:4

Synthesis of alogliptin benzoate and its preliminary quality control
下载PDF
导出
摘要 目的借助HPLC法对苯甲酸阿格列汀合成的各步中间体和产品进行质量控制,并对有关物质进行检测,优化其合成工艺路线,为工业化生产奠定基础。方法以6-氯-3-甲基尿嘧啶为起始原料,通过2次亲核取代、氯化氢乙酸乙酯脱Boc再与苯甲酸成盐,完成本品的合成。并对本品合成涉及的各步中间体、终产品及主要有关物质的HPLC检测方法进行优化,用于有效追踪合成过程和产品检测。结果本方法合成苯甲酸阿格列汀的总收率达52.6%~57.0%,纯度达99.5%,单杂均小于0.1%。结论改进后的合成工艺操作简便、反应条件温和,重现性好,更适合工业化生产。优化的HPLC方法专属性强、灵敏度高,可以有效监测产品质量。 Objective To improve the synthetic route of alogliptin benzoate, a reliable HPLC analytical method to control the quality of intermediates, and compounds for industrial production. Methods Alogliptin benzoate was synthesized as follows: starting from 6-chloro-3-methyl uracil, after 2 successive nucleophilic substitutions, removal of Boc group with hydrogen chloride in ethyl acetate, and salt formation with benzoic acid. HPLC was used to detect some materials including all chromatographs of the intermediates, products and related compounds. This method optimized the synthetic route of alogliptin benzoate. Results The product was synthesized at 52.6%- 57.0% total yield, with purity more than 99.5%, and any related impurity minimized to less than 0.1%. Conclusion The product meets the quality requirement of HPLC-detection. The improvement is simple with mild reaction conditions and good reproducibility, and is suitable for industrial production. The improved HPLC method is also specific and highly sensitive.
出处 《中南药学》 CAS 2016年第8期813-816,共4页 Central South Pharmacy
关键词 苯甲酸阿格列汀 二肽基肽酶-4抑制剂 高效液相色谱法 合成工艺 alogliptin benzoate DPP-IV inhibitor HPLC synthesis
  • 相关文献

参考文献6

二级参考文献25

  • 1Feng J,Zhang Z,Wallace MB,et al.Discovery of alogliptin:A potent,selective,bioavailabe,and efficacious inhibitor of dipeptidyl peptidase IV[J].J Med Chem,2007,50(10):2297-2300.
  • 2Serradell N,Rose E,Bolos J.Alogliptin benzoate[J].Drug Future,2008,33(1):7-12.
  • 3Feng J,Gwaltney SL,Stafford JA,et al.Dipeptidyl peptidase inhibitors:WO,2007035629[P].2006,9,15.
  • 4Ludescher J, Wieser J, Laus G, et al. Process for thepre- paration of alogliptin and its benzoate salts: WO, 2010072680[P].2010-07-01.
  • 5Ghatak S B, Patel D S, Shanker N, et al. Alogliptin : a novel molecule for improving glycemic control in type II diabetes inellitus[J]. Curt Diabetes Rev,2010,6(6) :410-421.
  • 6Harada K,Fukuyama,Koike M. Laminated tablet and manu- facturing methodtherefor [P]. US :20140023708,2014-01-23.
  • 7Serradell N, Rosa E, Bolos J. Alogliptin benzoate [J]. Drug Future,2008,33 ( 1 ) :7-12.
  • 8Feng J, Gwaltney S L, Stafford J A, et al. Dipeptidyl pepti- dase inhibitors[P]. WO :2007 035629,2006-09-15.
  • 9Schareina T, Zapf A, Beller M, et al. Improving palladium- catalyzed cyanation of aryl halides : development of a state- of-the-art methodology using potassium hexacyanoferrate ( II ) as cyanating agent [J]. J Org Chem, 2004,689 : 4 576-4 583.
  • 10Schareina T, Zapf A, Belier M, et al. Potassium hexacyano- ferrate( II )-a new cyanatinga gent for the palladium-cata- lyzed cyanation of arylhalides[J]. Chem Commun ,2004,1388-1 389.

共引文献25

同被引文献21

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部